Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2012
12/12/2012CN102816856A Application of DIAPH3 gene and expression product thereof
12/12/2012CN102816816A Bacillus sphaericus parasporal crystal protein preparation method and application thereof
12/12/2012CN102816792A Method for regulating expression, quantity and activity of heat shock protein 70 and application thereof
12/12/2012CN102816770A Cotesia plutellae antimicrobial peptide defensin gene, antimicrobial peptide and application
12/12/2012CN102816769A Hermetia illucens L antibacterial peptide, preparation method and application thereof
12/12/2012CN102816768A Prawn transcription activation reaction RNA binding protein and purpose thereof
12/12/2012CN102816743A Human ubiquitin ligase E3 for the modulation of NF-Kappa B
12/12/2012CN102816738A Dermal micro-organs, methods and apparatuses for producing and using the same
12/12/2012CN102816245A Synthetic antibacterial protein group and preparation method and application thereof
12/12/2012CN102816244A Fusion protein of exendin-4 peptide and human serum albumin (HSA) and preparation method thereof
12/12/2012CN102816242A Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
12/12/2012CN102816240A Fusion protein and fusion protein expression vector thereof
12/12/2012CN102816228A Single-chain insulin
12/12/2012CN102816225A Metastatic tumor deletion protein inhibitor polypeptide
12/12/2012CN102816223A Brachymystax lenok Cathelicidin antimicrobial peptide CATH_BARLE, and gene, preparation and application thereof
12/12/2012CN102816215A Smallish polypeptide capable of inhibiting HIV and medicinal use thereof
12/12/2012CN102816214A Artificial transcription factor of hepatitis B virus (HBx) genes and application of artificial transcription factor
12/12/2012CN102816212A Rubiaceae-type cyclopeptide, its pharmaceutical composition and application
12/12/2012CN102816209A Chemokine-derived peptide, its expression gene and application thereof
12/12/2012CN102816206A Synthetic peptide and application thereof
12/12/2012CN102816205A Beta-profilin 1, and fragment and applications thereof
12/12/2012CN102816203A Substituted quinoline compound, and preparation method, medicine combination and application thereof
12/12/2012CN102813941A Application of growth factor gene drug in preventing and treating stress-related gastrointestinal injury
12/12/2012CN102813923A Combination Therapy for the Treatment of Ocular Neovascular Disorders
12/12/2012CN102813914A Medicinal composition used for treating or preventing cerebrovascular disease and related diseases
12/12/2012CN102813913A Sichuan blackberry extract composition
12/12/2012CN102813912A Preparation assisting acupoint massage as well as preparation process and application thereof
12/12/2012CN102813911A Medicine used for treating constipation
12/12/2012CN102813910A Medicine composition used for controlling poultry airsacculitis, and preparation method thereof
12/12/2012CN102813909A Compound doxycycline hydrochloride composition for preventing and treating colibacillosis and chronic respiratory disease of poultry as well as preparation method thereof
12/12/2012CN102813908A Lyophilization technology for preparing bivalirudin for injection
12/12/2012CN102813907A Medicine composition for treating cerebrovascular accident sequela and preparation method and application thereof
12/12/2012CN102813753A Composition containing Cistanche deserticola or Herba Cynomorii and combination of chrysanthemum, taurine, lycopene, xanthophyll and beta-carotene
12/12/2012CN102813676A Novel application for polypeptide extracts from scapharca subcrenata to immune adjustment
12/12/2012CN102813637A Kallidinogenase enteric coated tablet and preparation method thereof
12/12/2012CN102813632A Stable thymalfasin preparation and preparation method thereof
12/12/2012CN102286435B Regulatory-cytokine-induced anti-apoptotic molecule (CIAPIN1) recombinant adenovirus and preparation method and use thereof
12/12/2012CN102242127B Preparation method of serial antibacterial peptide Alloferon-1 and application of rAlloferon-1-K
12/12/2012CN102205114B Application of erythropoietin source peptide to preparation of medicament for treating autoimmune disease of nervous system
12/12/2012CN102154482B Application of calcium activated chloride channels ANO1/TMEM16A in diagnosis and treatment of prostate cancer
12/12/2012CN102106540B Freckle-removal beautifying biological composition
12/12/2012CN101906136B Amino acid-(3,4-dyhydroxy-Phe)-Ser-Leu false peptide, and synthesizing method and application thereof
12/12/2012CN101837117B Application of B cell epitope peptide from tetanus exotoxin fragment C
12/12/2012CN101835486B Pharmaceutical composition and related methods
12/12/2012CN101772507B Proteasome inhibitors
12/12/2012CN101560243B Method for separating and purifying abrin and product thereof
12/12/2012CN101547684B Ejection liquid and ejection method
12/12/2012CN101511380B Pharmaceutical compositions for sustained release delivery of peptides
12/12/2012CN101319247B IL-2 selective agonists and antagonists
12/12/2012CN101123978B Neublastin variants
12/12/2012CN101056539B Modulating phosphatase activity in cardiac cells
12/11/2012US8330026 Derivatives of the NF-κB inducing enzyme, their preparation and use
12/11/2012US8329946 Histone deacetylases, and uses related thereto
12/11/2012US8329945 Histone deacetylases, and uses related thereto
12/11/2012US8329890 SiRNA-mediated gene silencing
12/11/2012US8329870 Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
12/11/2012US8329866 Long acting VEGF inhibitors and methods of use
12/11/2012US8329865 Antimicrobially active peptides
12/11/2012US8329864 Agent derived from tortoise spleen stimulating mammalian hemopoiesis
12/11/2012US8329863 Gonadotropin releasing hormone antagonists
12/11/2012US8329862 Cell-killing peptide derived from the C-terminus of NOXA protein
12/11/2012US8329859 Peptides that home to tumor lymphatic vasculature and methods of using same
12/11/2012US8329760 Pharmaceutical composition
12/11/2012US8329749 Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia
12/11/2012US8329727 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
12/11/2012US8329671 Reduction of dermal scarring
12/11/2012US8329662 Prodrug of an ICE inhibitor
12/11/2012US8329661 Method for using HIP/PAP polypeptide composition for liver regeneration and prevention of liver failure
12/11/2012US8329659 SAP variants and their use
12/11/2012US8329658 Arylalkyl and heteroarylalkyl derivatives of cyclosporine A for the treatment and prevention of viral infection
12/11/2012US8329657 Fn14/TRAIL fusion proteins and method of treating cancer
12/11/2012US8329656 Use of a PDE5 inhibitor for treating and preventing hypopigmentary disorders
12/11/2012US8329654 Use of IL-6/IL-6 chimera in Huntington's disease
12/11/2012US8329653 Compositions and methods for suppression of amyloid plaque formation associated with neurodegenerative disorders
12/11/2012US8329649 Aqueous composition containing follicle-stimulating hormone and histidine
12/11/2012US8329648 Methods for treating diabetes and reducing body weight
12/11/2012US8329646 Methods for the treatment of muscle loss
12/11/2012US8329645 Polymyxin derivatives and uses thereof
12/11/2012US8329644 Lantibiotic-based compounds having antimicrobial activity
12/11/2012US8329642 Formula and method to enhance external physiognomy
12/11/2012US8329641 Antiischemic agents; anticholesterol agents; cardiovascular disorders; using granulocyte colony stimulating agents
12/11/2012US8329640 Peptides with improved properties having the biological activity of vasoactive intestinal peptide (VIP) and their use for the treatment of lung diseases
12/11/2012US8329639 MUC1 based glycolipopeptide vaccine with adjuvant
12/11/2012US8329638 Antibacterial agent based on fatty acid esters of hydroxy carboxylic acids
12/11/2012US8329637 Immunosuppression and antigen-specific immune tolerance; allogenic organ rejection, graft versus host disease, type I diabetes, rheumatoid arthritis, multiple sclerosis, systemic lupus erithematosus; chronic inflammatory disease; Crohn's disease and ulcerative colitis; asthma
12/11/2012US8329463 RNA interference mediating small RNA molecules
12/11/2012US8329391 entail analysis of the pyro-glutamate (gyro-Glu) content of the glatiramer acetate in a sample; for multiple sclerosis
12/11/2012US8329225 Antioxidant polymer nanocarriers for use in preventing oxidative injury
12/11/2012US8329220 Controlled release formulations
12/11/2012US8329215 Shell and core dosage form approaching zero-order drug release
12/11/2012US8329211 Reinforced absorbable multi-layered fabric for hemostatic applications
12/11/2012US8329209 Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
12/11/2012US8329197 Ex vivo uses of immunostimulatory combinations
12/11/2012US8329192 Campylobacter polypeptides and methods of use
12/11/2012US8329191 Three-branched polyethylene glycol-G-CSF conjugate
12/11/2012US8329186 Treatment of inflammation using BST2 inhibitor
12/11/2012US8329185 Method for isolating and purifying grass pollen allergens
12/11/2012US8329172 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
12/11/2012US8329171 Method for treating psoriatic arthritis by administering an anti-IL-12 antibody
12/11/2012US8329169 Methods and compositions for the prevention and treatment of sepsis